Cinacalcet for secondary hyperparathyroidism in children with end-stage renal disease

Pediatric Nephrology

Volumn 23, Issue 10, 2008, Pages 1823-1829

  Muscheites, Jutta ^a,b   Wigger, Marianne ^a   Drueckler, Erdmute ^a   Fischer, Dagmar Christiane ^a   Kundt, Guenther ^a   Haffner, Dieter ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

Author keywords

Calcimimetics; Cincacalcet; End stage renal disease; Hypercalcemia; Hyperphosphatemia; Secondary hyperparathyroidism

Indexed keywords

CALCITRIOL; CALCIUM; CALCIUM ACETATE; CINACALCET; COLECALCIFEROL; PARATHYROID HORMONE; PHOSPHATE BINDING AGENT; PHOSPHORUS; SEVELAMER; VITAMIN D DERIVATIVE;

ADOLESCENT; ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DISEASE CONTROL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL TOXICITY; HEMODIALYSIS; HUMAN; HYPOCALCEMIA; KIDNEY FAILURE; MALE; NAUSEA; OUTCOME ASSESSMENT; PARATHYROID HORMONE BLOOD LEVEL; PERITONEAL DIALYSIS; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; REFERENCE VALUE; SECONDARY HYPERPARATHYROIDISM; TREATMENT DURATION; VOMITING;

ADOLESCENT; ADULT; CALCIUM; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; INFANT; KIDNEY FAILURE, CHRONIC; MALE; NAPHTHALENES; PARATHYROID HORMONE; PHOSPHORUS;

EID: 51549087339     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-008-0810-5     Document Type: Article

References (31)

1. Chesney RW, Moorthy AV, Eisman JA, Jax DK, Mazess RB, DeLuca HF (1978) Increased growth after long-term oral 1alpha,25-vitamin D3 in childhood renal osteodystrophy. N Engl J Med 298:238-242
2. Mehls O, Wuhl E, Haffner D, Schaefer F, Tonshoff B (1996) Growth hormone treatment of short children with chronic renal failure before and after renal transplantation: Rationale and recent results. Nephrol Dial Transplant 11:1747-1750
3. Parfitt AM (1997) The hyperparathyroidism of chronic renal failure: A disorder of growth. Kidney Int 52:3-9
4. Slatopolsky E, Delmez JA (1994) Pathogenesis of secondary hyperparathyroidism. Am J Kidney Dis 23:229-236
5. Wuhl E, Haffner D, Nissel R, Schaefer F, Mehls O (1996) Short dialyzed children respond less to growth hormone than patients prior to dialysis. German Study Group for Growth Hormone Treatment in Chronic Renal Failure. Pediatr Nephrol 10:294-298
6. Pieper AK, Haffner D, Hoppe B, Dittrich K, Offner G, Bonzel KE, John U, Frund S, Klaus G, Stubinger A, Duker G, Querfeld U (2006) A randomized crossover trial comparing sevelamer with calcium acetate in children with CKD. Am J Kidney Dis 47:625-635
7. Briese S, Wiesner S, Will JC, Lembcke A, Opgen-Rhein B, Nissel R, Wernecke KD, Andreae J, Haffner D, Querfeld U (2006) Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease - impact of calcium and vitamin D therapy. Nephrol Dial Transplant 21:1906-1914
8. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB (2000) Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342:1478-1483
9. Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, Mehls O, Schaefer F (2002) Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106:100-105
10. Kuizon BD, Goodman WG, Juppner H, Boechat I, Nelson P, Gales B, Salusky IB (1998) Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD. Kidney Int 53:205-211
11. Nemeth EF, Steffey ME, Hammerland LG, Hung BC, Van Wagenen BC, DelMar EG, Balandrin MF (1998) Calcimimetics with potent and selective activity on the parathyroid calcium receptor. Proc Natl Acad Sci U S A 95:4040-4045
12. Block GA, Martin KJ, de Francisco AL, Turner SA, Avram MM, Suranyi MG, Hercz G, Cunningham J, Abu-Alfa AK, Messa P, Coyne DW, Locatelli F, Cohen RM, Evenepoel P, Moe SM, Fournier A, Braun J, McCary LC, Zani VJ, Olson KA, Drueke TB, Goodman WG (2004) Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 350:1516-1525
13. Chertow GM, Blumenthal S, Turner S, Roppolo M, Stern L, Chi EM, Reed J (2006) Cinacalcet hydrochloride (Sensipar) in hemodialysis patients on active vitamin D derivatives with controlled PTH and elevated calcium × phosphate. Clin J Am Soc Nephrol 1:305-312
14. El-Amm JM, Doshi MD, Singh A, Migdal S, Morawski K, Sternbauer D, Cincotta E, West MS, Losanoff JE, Gruber SA (2007) Preliminary experience with cinacalcet use in persistent secondary hyperparathyroidism after kidney transplantation. Transplantation 83:546-549
15. Goodman WG, Hladik GA, Turner SA, Blaisdell PW, Goodkin DA, Liu W, Barri YM, Cohen RM, Coburn JW (2002) The calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism. J Am Soc Nephrol 13:1017-1024
16. Lindberg JS, Moe SM, Goodman WG, Coburn JW, Sprague SM, Liu W, Blaisdell PW, Brenner RM, Turner SA, Martin KJ (2003) The calcimimetic AMG 073 reduces parathyroid hormone and calcium × phosphorus in secondary hyperparathyroidism. Kidney Int 63:248-254
17. Martin KJ, Juppner H, Sherrard DJ, Goodman WG, Kaplan MR, Nassar G, Campbell P, Curzi M, Charytan C, McCary LC, Guo MD, Turner SA, Bushinsky DA (2005) First- and second-generation immunometric PTH assays during treatment of hyperparathyroidism with cinacalcet HCl. Kidney Int 68:1236-1243
18. Moe SM, Cunningham J, Bommer J, Adler S, Rosansky SJ, Urena-Torres P, Albizem MB, Guo MD, Zani VJ, Goodman WG, Sprague SM (2005) Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl. Nephrol Dial Transplant 20:2186-2193
19. Quarles LD, Sherrard DJ, Adler S, Rosansky SJ, McCary LC, Liu W, Turner SA, Bushinsky DA (2003) The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease. J Am Soc Nephrol 14:575-583
20. Serra AL, Savoca R, Huber AR, Hepp U, Delsignore A, Hersberger M, Wuthrich RP (2007) Effective control of persistent hyperparathyroidism with cinacalcet in renal allograft recipients. Nephrol Dial Transplant 22:577-583
21. Szwarc I, Argiles A, Garrigue V, Delmas S, Chong G, Deleuze S, Mourad G (2006) Cinacalcet chloride is efficient and safe in renal transplant recipients with posttransplant hyperparathyroidism. Transplantation 82:675-680
22. Goodman WG (2003) Calcimimetic agents and secondary hyperparathyroidism: rationale for use and results from clinical trials. Pediatr Nephrol 18:1206-1210
23. Payne RB, Carver ME, Morgan DB (1979) Interpretation of serum total calcium: Effects of adjustment for albumin concentration on frequency of abnormal values and on detection of change in the individual. J Clin Pathol 32:56-60
24. Langman CB, Salusky IB, Greenbaum L, Jueppner H, Leonard M, Nelson P, Portale A, Warady BA (2005) K/DOQI Clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease. Am J Kidney Dis 46:1-121
25. Ishizuya T, Yokose S, Hori M, Noda T, Suda T, Yoshiki S, Yamaguchi A (1997) Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells. J Clin Invest 99:2961-2970
26. Schmitt CP, Hessing S, Oh J, Weber L, Ochlich P, Mehls O (2000) Intermittent administration of parathyroid hormone (1-37) improves growth and bone mineral density in uremic rats. Kidney Int 57:1484-1492
27. Wada M, Furuya Y, Kobayashi N, Kobayashi N, Miyata S, Ishii H, Nagano N (2003) The calcimimetic compound AMG 073 (cinacalcet HCl) ameliorates osteitis fibrosa in rats with chronic renal insufficiency. J Am Soc Nephrol 14:48A
28. Daschner M, Philippin B, Nguyen T, Wiesner RJ, Walz C, Oh J, Sandow J, Mehls O, Schaefer F (2002) Circulating inhibitor of gonadotropin releasing hormone secretion by hypothalamic neurons in uremia. Kidney Int 62:1582-1590
29. Haffner D, Schaefer F, Nissel R, Wuhl E, Tonshoff B, Mehls O (2000) Effect of growth hormone treatment on the adult height of children with chronic renal failure. German Study Group for Growth Hormone Treatment in Chronic Renal Failure. N Engl J Med 343:923-930
30. Schaefer F, Seidel C, Binding A, Gasser T, Largo RH, Prader A, Scharer K (1990) Pubertal growth in chronic renal failure. Pediatr Res 28:5-10
31. Nakagawa K, Geldyyev A, Oh J, Gross ML, Santos F, Schaefer F, Schmitt CP (2006) Calcimimetics do not alter epiphyseal growth in healthy and uremic rats. J Am Soc Nephrol 17:132A